Interní Med. 2009; 11(2): 84-86
Is pharmacotherapy after myocardial infarction sufficient?
- II. interní klinika FN u sv. Anny LF MU, Brno
We present a review of pharmacotherapy of patients after myocardial infarction in Europe, in university hospitals in the Czech Republic.
A large number of patients is treated with recommended drug groups – ACE – inhibitors, AT1 blockers, beta blockers, antiplatelet therapy
and hypolipidemic treatment and data from the Czech Republic are rather better than in other European countries. The reach of target blood pressure and cholesterol is however insufficient and nonpharmacological treatment is probably insufficient, too, mainly prevention of smoking and overweight of patients.
Keywords: myocardial infarction, ACE-inhibitor, beta blocker, antiplatelet treatment, statin.
Published: April 1, 2009 Show citation
References
- ©imon J, et al. Epidemiologie a prevence ischemické choroby srdeční. 1. vyd. Praha, Grada Publishing 2001; 264 s.
- ©pinar J, Vítovec J, et al. Ischemická choroba srdeční. 1. vyd. Praha, Grada Publishing 2003; 364 s.
- De Wood, MA, Spores J, Norské RN, Mouser LT, Burroughs R, Golden MS, Lang HT. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction, N Eng J Med 1980; 303: 897-902.
Go to original source... 
Go to PubMed... - Weaver WD, Simes RJ, Betriu A, et al. For the Primary Coronary Angioplasty versus Thrombolysis Collaboration Group. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative overview, JAMA 1997; 278: 2093-2098. Go to original source... Go to PubMed...
- EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997; 18: 1569-1582. Go to PubMed...
- EUROASPIRE. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554-572. Go to original source... Go to PubMed...
- EUROASPIRE. Hodnocení pokroku v sekundární prevenci ICHS. Medicína 2001; 5: 12.
- Wood DA. Euro Heart Survey Programme - Euroaspire III. ústní sdělení, www.escardio.org.
- Hanuą P, Faltus V, Grunfeldová H et al. Léčba akutního infarktu myokardu - guidelines a klinická praxe podle dat z pilotního projektu registru infarktu myokardu z let 2003-2007. Cor Vasa 2008; 50 (9): 159.